In AML cancerous states, PDXK constitutively phosphorylates PL and PN into PLP, thereby promoting cancer cell proliferation, while a dominant negative PDXK mutant was unable to restore PLP levels or the proliferative effects of AML cells [136]. The gene discussed is PDXK; the disease is cancer.